Nuestro equipo

1. De Pablo F, Miralles J, Hernández ER, García C, Corrales JJ, De Castro S: Study of kinetics of the thyroid hormones and the peripheral conversion rate of Thyroxin to Triiodothyronine in Acute Renal Insufficiency under experimental condition. Horm. Met. Res., 12: 529, 1980.

2. Hernández ER: El feto como paciente. JANO, 593: 34, 1982.

3. De Pablo F, Roth J, Hernández ER, Pruss RM: Insulin is present in Chicken Eggs and early Chick Embryos. Endocrinology, 111: 1909, 1982.

4. Taylor S, Dons RF, Hernández ER, Roth J, Gorden PH: Insulin Resistance Associated with Androgens excess in Women with Autoantibodies to the Insulin Receptor. Ann. Inter. Med., 97: 851, 1982.

5. De Pablo F, Hernández ER, Collia F, Gómez JA: Untoward effects of pharmacological doses of insulin in early chick embryos: Through which receptor are they mediated? Diabetología, 28: 308, 1985.

6. De Pablo F, Girbau M, Gómez JA, Hernández ER, Roth J: Insulin antibodies retard and insulin accelerates growth and differentiation in early embryos. Diabetes, 34: 1063, 1985.

7. De Pablo F, Lesniak M, Hernández ER, LeRoith D, Shiloach J, Roth J: Extracts of protozoa contain materials that react specifically in the immunoassay for guinea pig insulin. Horm. Met. Res., 18: 82, 1986.

8. Hernández ER, Twardzik DR, Purchio A, Adashi EY: Gonadotropin-dependent ovarian transforming growth factor- β gene expression. Biol. Reprod., 36: 58A, 1987.

9. Kudlow JE, Kobrin MS, Purchio AF, Twardzik DR, Hernández ER, Asa SL, Adashi EY: Ovarian transforming growth factor-β gene expression: Immunohistochemical localization to the theca-interstitial cells. Endocrinology, 121: 1577, 1987

10. Hernández ER, Resnick CE, Holtzclaw WD, Payne DW, Adashi EY: Insulin as a regulator of androgen biosynthesis by cultured rat ovarian cells: Cellular mechanism(s) underlying physiologic and pharmacological hormonal action. Endocrinology, 122 :2034, 1988.

11. Hernández ER, Resnick CE, Svoboda ME, Van Wyk JJ, Payne DW, Adashi, EY: Somatomedin-C/Insulin-like growth factor-I (Sm-C/IGF-I) as an enhancer of androgen biosynthesis cultured rat ovarian cells. Endocrinology, 122: 1603, 1988.

12. Adashi EY, Resnick CE, Hernández ER, Svoboda ME, Van Wyk JJ: Characterisation and regulation of a specific cell membrane receptor for somatomedin-C/insulin-like growth factor-I in cultured rat granulosa cells. Endocrinology, 122: 194, 1988.

13. Adashi EY, Resnick CE, Hernández ER, May JV, Knecht M, Svoboda ME, Van Wyk JJ: Somatomedin-C/insulin-like growth factor I as an amplifier of follicle stimulating hormone action: Studies on mechanism(s) and site(s) of action in cultured rat granulosa cells. Endocrinology, 122: 1583, 1988.

14. Hernández ER, Jiménez JL, Payne DW, Adashi EY: Adrenergic regulation of ovarian androgen biosynthesis is mediated via P2-adrenergic theca-interstitial cell recognition sites. Endocrinology, 122: 1592, 1988.

15. Adashi EY, Resnick CE, Hernández ER, Svoboda ME, Hoyt E, Clemmons D, Lund PK and Van Wyk JJ: Insulin-like growth factor I: A paradigm for putative intraovarian regulators. In: Hodgen, G.D., Rosenwaks, Z., Spieler, J.M. (eds.), Non-steroidal Gonadal Factors: Physiological Roles and Possibilities in Contraceptive Development. The Jones Institute Press, Norfolk, Virginia, p. 314, 1988.

16. Adashi EY, Resnick CE, Hernández ER, Svoboda ME, Van Wyk JJ: In vivo regulation of granulosa cell somatomedin-C/insulin-like growth factor-I receptors. Endocrinology, 122: 1383, 1988.

17. Adashi EY, Hernández ER, Resnick CE, Purchio AF, Twardzik DR, May JV: Ovarian transforming growth factor-β (TGF-β): site(s) and mechanism(s) of action. Mol. Cell. Endocrinol., 61: 247, 1989.

18. Adashi EY, Resnick CE, Hernández ER, Svoboda ME, Hoyt E, Clemmons D, Lund PK, Van Wyk JJ: Rodent studies on the potential relevance of IGF-I to ovarian function. In: Hirshfield, A.N. (ed.), Growth Factors and the Ovary. Plenum Press, New York, p. 95-107, 1989.

19. Adashi EY, Resnick CE, Hernández ER, Svoboda ME, Van Wyk JJ: The potential relevance of insulin-like growth factor I to ovarian physiology: From Basic Science to Clinical Application. Semi. Reprod. Endocrinol., 7: 94, 1989.

20. Hernández ER, Roberts CT,Jr., LeRoith D, Adashi EY: Rat ovarian insulin-like growth factor I (IGF-I) gene expression is granulosa cell-selective: 5’UT mRNA variant representation and hormonal regulation. Endocrinology, 125: 572, 1989.

21. Hurwitz A, Hernández ER, Resnick CE, Packman JN, Payne D, Adashi EY: Basic fibroblast growth factor (B-FGF) inhibits gonadotropin-supported ovarian androgen biosynthesis: Mechanism(s) and site(s) of action. Endocrinology, 126: 3089, 1990.

22. Adashi EY, Resnick CE, Hernández ER, Hurwitz A, Rosenfeld RG: Follicle-stimulating hormone inhibits the constitutive release of insulin-like growth factor binding proteins by cultured rat ovarian granulosa cells. Endocrinology, 126: 1305, 1990.

23. Hernández ER, Purchio AF, Dhamarajan AM, Payne DW, Hurwitz A, Adashi, EY: Transforming growth factor-β (TGF-β) inhibits ovarian androgen production: Gene expression, cellular localisation, mechanism(s), and site(s) of action. Endocrinology, 127: 2804, 1990.

24. Hernández ER, Roberts CT,Jr., Hurwitz A, LeRoith D, Adashi EY: Rat ovarian insulin-like growth factor II gene expression is theca-interstitial cell-exclusive: Hormonal regulation and receptor distribution. Endocrinology, 127: 3249, 1990.

25. Adashi EY, Resnick CE, Hernández ER, Svoboda ME, Van Wyk JJ: Ovarian insulin-like growth factor I: Basic concepts leading to potential clinical outlets. In: LeRoith, D., Raizada, M.K. (eds.). Plenum Publishing Corp., New York, p. 141-151, 1989.

26. Adashi EY, Resnick CE, Hernández ER, Hurwitz A, Roberts CT,Jr., LeRoith D, Rosenfeld RG, Svoboda ME, Van Wyk JJ: The ovarian IGF-1 system as a paradigm for putative intraovarian regulators. In: Cittadini E, DeCecco L, Massi GB (Eds), Fertilita e Sterilita, Cosesa Edizioni, 1991,Volume 1, pp 209-213.

27. Adashi EY, Resnick, CE, Hurwitz A, Ricciarelli A, Hernández ER, Rosenfeld RG, Roberts CT,Jr., LeRoith D: The potential relevance of IGFs to ovarian physiology: Recent developments. Contraception. Fertilite’Sexualite, 19, pp 29-34, 1991.

28. Adashi EY, Resnick CE, Hernández ER, Hurwitz A, Roberts CT,Jr., LeRoith D, Rosenfeld RG, Svoboda ME, Van Wyk JJ: The ovarian IGF-I system as a paradigm for putative intraovarian regulators: In: Yen, S.S.C.and Vale, W.W. (eds.), Advances in Neuroendocrine Regulation of Reproduction: Basic and Clinical Aspects. Plenum Press, New York, 1990.

29. Adashi EY, Resnick CE, Hernández ER, Hurwitz A, Roberts CT,Jr., LeRoith D, Rosenfeld RG: The intraovarian Insulin-Like Growth Factor-I System. In: Schomberg, D.W. (ed.), Growth Factors in Reproduction. Plenum Press, New York, 1990. (pp 91).

30. Adashi EY, Resnick CE, Hernández ER, Svoboda ME, Hoyt E, Clemmons DR, Lund PK, Van Wyk JJ: Ovarian insulin-like factor-I: Basic and clinical implications. In: Haseltime, F.P. and Findlay, J. (eds.), Growth Factors in Fertility Regulations, 1990. (pp 117).

31. Adashi EY, Resnick CE, Hernández ER, Hurwitz A, Roberts CT,Jr., LeRoith D, Rosenfeld RG: The intraovarian IGF System. In: Dunaif, A., Givens, J.R., Haseltime, F.P. and Merriam, G.R. (eds.), The Polycystic Ovary Syndrome. Blackwell Scientific Publications, Inc., 1990. (pp 213).

32. Adashi EY, Resnick CE, Hernández ER, Hurwitz A, Rosenfeld, RG: Ovarian granulosa cell-derived insulin-like growth factor (IGF) binding proteins: Constitutive release of low molecular weight, high-affinity IGF-selective species. Mol. Cell. Endocrinol., 74: 175, 1990.

33. Adashi EY, Resnick CE, Hurwitz A, Ricciarelli E, Hernández ER, Rosenfeld RG: Ovarian granulosa cell-derived insulin-like growth factor binding proteins: Modulatory role of follicle-stimulating hormone. Endocrinology, 128: 754, 1990.

34. Adashi EY, Resnick CE, Hernández ER, Hurwitz A, Roberts CT,Jr., LeRoith D, Van Wyk JJ, Rosenfeld RG: Insulin-like growth factor-I as an intraovarian regulator: Basic and clinical implications. In: Seppala, M.and Hamberger L, (eds.), Frontiers in Human Reproduction. Ann. New York Acad. Sci., 626: 161, 1991.

35. Hernández ER, Roberts CT,Jr., Hurwitz A, Ricciarelli E, LeRoith D, Adashi EY: Rat ovarian insulin-like growth factor-I and II gene expression: Hormonal regulation and cellular localisation. In: Proceedings of the Second Sapparo International Symposium on Ovarian Function, T. Tanaka (ed.). Raven Press, 1991.

36. Hurwitz A, Hernández ER, Resnick CE, Packman JN, Payne DW, Adashi EY: Cytokine mediated regulation of ovarian function: Interleukin-I inhibits gonadotropin-induced androgen biosynthesis. Endocrinology, 129: 1250, 1991.

37. Adashi EY, Resnick C, Hernández ER, Hurwitz A, Roberts CT, LeRoith D, Rosenfeld RG. The intraovarian IGF system. ln: Shomber DW (ed). Growth Factors in Reproduction, Springer-Verlag, NY, pp 91, 1991.

38. Adashi EY, Resnick CE, Vera A, Hernández ER: In vivo regulation granulosa cell type I insulin-like growth factor receptors: Evidence for an inhibitory role for the putative endogenous ligand(s) of the ovarian GnRh receptors. Endocrinology, 128: 3130, 1991.

39. Adashi EY, Resnick CE, Hurwitz A, Hernández ER,: The ovarian IGF-I System. In: Spencer, EM (ed.), Modern Concepts of Insulin-like Growth Factors. Elsevier Science Publising Co., N.Y., 1991. (pp 267).

40. Adashi EY, Resnick CE, Hernández ER, Hurwitz A, LeRoith D, Roberts CT,Jr., Rosenfeld R, Svoboda ME, Van Wykk JJ: Growth factors and follicle function. In: Adashi EY, Mancuso S, Caruso A, Fulghern AM, Lanzone A (eds.) pg 111, 1991.

41. Ricciarelli E, Hernández ER, Hurwitz A, Kokia E & Rosenfeld RG, Schwander J, Adashi EY: The ovarian expression of the antigonadotropic IGFBP-2 is theca-interstitial cell-selective: Evidence for hormonal regulation. Endocrinology, 129: 2266, 1991.

42. Hernández ER, Hurwitz A, Botero L, Ricciarelli E, Werner H, Roberts CT,Jr., LeRoith D, Adashi EY: The insulin-like growth factor receptor gene family in the rat ovary: Divergent regulation of distinct receptor species. Mol. Endocrinol., 5: 1799, 1991.

43. Adashi EY, Resnick CE, Hurwitz A, Ricciarelli E, Hernández ER, Roberts CT,Jr., LeRoith D, Rosenfeld RG: Insulin-like growth factors: The ovarian connection. Human. Reprod., 6: 1206, 1991.

44. Hurwitz A, Ricciarelli E, Botero L, Rohan RM, Hernández ER, Adashi EY: Endocrine-mediated and autocrine-mediated regulation of rat ovarian (theca-interstitial) interleukin I beta gene expression. Gonadotropin-dependent preovulatory acquisition. Endocrinology, 129: 3427, 1991.

45. Adashi EY, Resnick CE, Hurwitz A, Ricciarelli E, Hernández ER, Rosenfeld RG: Ovarian granulosa cell-derived insulin-like growth factor binding proteins: Modulatory role of follicle-stimulating hormone. Endocrinology, 128: 745, 1991.

46. Adashi EY, Resnick C, Ricciarelli E, Hurwith A, Kokia E, Botero LF, Tedeschi C, Hernández ER, Koistinen R, Rutanen EM, Seppala M. Local tissue modification of follicle-stimulating hormone action. In: Genazzani AR, Petraglia F (eds). Hormones in Gynaecological Endocrinology. The Parthenon Publishing Group, Lancs, England, pp 255, 1992.

47. Adashi EY, Resnick CE, Ricciarelli E, Hurwitz A, Hernández ER, Rosenfeld RG, Ballard FJ, Carlson-Skwirut C: Granulosa cell-derived insulin-like growth factor (IGF) binding proteins are inhibitory to IGF-I hormonal action: Evidence derived from the use of a truncated IGF-I analogue. J. Clin. Invest., 90: 1593, 1992.

48. Hurwitz A, Loukides J, Ricciarelli E, Botero L, Katz E, Mc Allister JM,Garcia J, Rohan RM, Adashi EY, Hernández ER: The human intraovarian Interleukin-1 (IL-1) system: highly-compartmentalised and hormonally- dependent regulation of the genes encoding IL-1, its receptor, and its receptor antagonist. J. Clin. Invest., 89: 1746, 1992.

49. Ricciarelli E, Hernández ER, Tedeschi C, Botero L, Kokia E, Rohan RG, Rosenfeld RG, Albiston AL, Herington AC, Adashi EY: Rat ovarian insulin-like growth factor binding protein-3-A Growth Hormone-Dependent Theca- Interstitial Cell-derived Antigonadotropin. Endocrinology, 130: 3092, 1992.

50. Adashi EY, Resnick CE, Ricciarelli E, Hurwitz A, Kokia E, Botero L, Tedesache C, Hernández ER, Koistinen R, Rutanen EM, Seppala M.Local tissue modification of FSH hormone action. In: Genazzani AR, Petraglia F (eds), Hormones in Gynecological Endocrinology. The Parthenon Publishing Group, Lancs, England, pp 255, 1992.

51. Hernández ER, Roberts CT,Jr., Hurwitz A, Ricciarelli E, LeRoith D, Adashi EY: Rat ovarian IGF-I and II gene expression: Hormonal regulation and cellular localisation. In: Fujimoto S, Mizuno M and Gegal Sj (Ed), Serono Symposia Review No 28, Recent Advances in Ovarian Function: Basic and Clinical Researches, pp 113, 1992.

52. Hernández ER, Hurwitz A, Pellicer A, Adashi EY, LeRoith D, Roberts CT,Jr: Expression of the insulin-like growth factor and insulin-like growth factor receptor gene families in the human ovary. J. Clin. Endo. Metab. 74: 419, 1992.

53. Adashi EY, Resnick C, Hernández ER, Hurwith A, Roberts CT, LeRoith D, Rosenfeld RG. The intraovarian IGF system. In Dunaif A, Givens JR, Haseltine FP, Merrian GR. (eds) Polycystic Ovarian Syndrome, Blackwell Scientific Publications Inc., pp 213, 1992.

54. Adashi EY, Resnick C, Hurwitz A, Kokia E, Ricciarelli E, Roberts CT, LeRoith D, Rosenfeld RG. The ovarian and testicular IGF system. In: Nieschlag E and Habenicht F, Molecular, cellular and endocrine events in male reproduction: Spermatogenesis, Fertilization, Contraception. Schering Foundation Workshop 4, Springer-Verlag, Berlin, pp 113, 1992.

55. Levy MJ, Hernández ER, Adashi EY, Stillman RJ, Roberts CT,Jr. and LeRoith D: Expression of IGF-I, IGF-II and the IGF-l and IGFII receptor genes during postnatal development of the rat ovary. Endocrinology, 131: 1202, 1992.

56. Phillip M, Palese T, Kowarski AH, Hernández ER, Roberts CT,Jr. and LeRoith D: Testosterone has no direct effect on hepatic IGF-I gene expression. Endocrinology, 130: 2865, 1992.

57. Adashi EY, Resnick CE, Hurwitz A, Ricciarelli E, Hernández ER, Roberts CT,Jr, LeRoith D, Rosenfeld R G. The intraovarian IGF System. Growth. Reg., 2: 10, 1992.

58. Adashi EY, Resnick CE, Hurwitz A, Kokia E, Ricciarelli E, Hernández ER, Roberts CT,Jr., LeRoith D, Rosenfeld RG. Ovarian Growth Factors: The IGF-I example. In Nieschlag E. (ed). Molecular and cellular endocrine events in male reproduction. Springer-Verlag, Berlin., pp.143, 1992.

59. Hurwitz A, Hernández ER, Payne D, Dharmarajan AM, Adashi EY.Interleukin-1 is both morphogenic and cytotoxic to cultured rat ovarian cells. Obligatory role for heterologous, contact-independent cell-cell interaction. Endocrinology, 131: 1643, 1992.

60. Botero L, Kokia E, Ricciarelli E, Roberts CT, LeRoith D, Adashi EY, Hernández ER: IGF-I gene and type I IGF gene expression by primary cultures of ovarian cells: Insulin and dexamethasone-dependence. Endocrinology, 132: 2703, 1993.

61. Adashi EY, Resnick CE, Hernández ER, LeRoith D, Robert CT,Jr and Rosenfeld RG: Intraovarian Regulators: The proposed role of IGFs. In: Chrousos GP (ed), Intraovarian regulators and Polycystic Ovarian Syndrome: Recent Progress in Clinical and Therapeutic Aspects, Ann. New York Acad. Sci., 1993.

62. Adashi EY, Resnick CE, Hurwitz A, Ricciarelli E, Hernández ER, Botero L, Roberts CT,Jr, LeRoith D, Rosenfeld RG: The intraovarian IGF System as a Paradigm for Intraovarian Regulators. In: Magness RR, Naftolin F. (Eds), Local Systems in Reproduction, 1993.

63. Hernández ER. IGF-I intraovarico, Boletin de la Sociedad Española de Fertilidad (SEF), 3:20, 1994

64. Hernandez ER. PCR en Reproducción. Boletin de la SEF, 4:10, 1995

65. Hernández ER, Ricciarelli E: Existe alguna relación entre el Premio Nobel y la temperatura de los testículos? Endocrinologia, 42: 35-36, 1995.66. Hernández ER. Regulation of the IGFs and their receptor genes by steroids and gonadotropins in the ovary. J. Steroid. Biochem. Molec. Biol,: 219-221, 1995.

67. Flyvberg A, Landau D, Domene H, Hernández ER, LeRoith D. The role of GH, IGF-Is and IGFBPs in experimental diabetic kidney disease. Metabolism, 44: 670-71, 1995.

68. Goya L, Rivero F, Martin MA, Hernández ER, Pascual-Leone AM. Effects of reefeding of undernourished and insulin treatment of diabetic neonatal rats on serum and liver mRNA expression of IGFs and IGFBPs. Am. J. Physical., 271: E223-E231, 1996.

69. Hernández ER, Ricciarelli E. Desarrollo folicular: Factores de Crecimiento. pg 50-62. Remohi J, Pellicer A (eds) 1996.

70. Hernández ER. Endocrinologia de la reproducción. En «Fundamentos Moleculares del Sistema Endocrino». Blazquez E (ed). 1996.

71. Porras A, Hernández ER, Benito M. Ras proteins mediate induction of uncoupling protein, IGF-I and IGF-I receptor in rat fetal brown adipocytes cell lines. DNA and Cell. Biol., 15: 921. 1996.

72. Hernández ER Apoptosis en Reproducción Humana. Boletin de SEF 6:10-14, 1997

73. Alcaide A, Hernández, ER. Infertilidad de origen masculino: tratamientos actuales. Endocrinología, 44:155-157, 1997.

74. Hernández ER. ICSI y Consejo Genético. Boletín de la SEF. 7: 223-24, 1998

75. Roldán ERS, Hernández ER. Descenso en la calidad del semen humano: contaminantes ambientales y microdelecciones del cromosoma Y. Endocrinología, 45: 298-302, 1998.

76. Hernández, ER. The clinical benefits of recombinant gonadotropins: The good, the bad and the ugly. Hum. Reprod.14:1417-1418, 1999.

77. Peramo B, Ricciarelli E, Hernández ER. Transferencia de embriones: La gran olvidada. Boletin de la SEF 8: 18-24, 1999

78. Hernández ER, Garcia-Bermudez M, Roldan E, Ricciareli E. Estudio previo a la reproducción asistida. Revista Iberoamericana de Fertilidad 4:19-22, 1999

79. Hernández ER. Todas las FSH son iguales ante los ojos del receptor. Boletín de la SEF 8: 32-33,1999

80. Cuadros J, Hernández ER. Clonación: Historia, técnica y utilidad. Revista Ibero-Americana de fertilidad 16: 65-68, 1999.

81. Peramo B, Ricciarelli E, Hernández ER. Blastocyst Transfer and Monocygotic Twinning. Fertil. Steril, 11:16-23, 1999.

82. Cuadros J, Hernández ER. Aspectos éticos de la clonación. Boletín de la SEF 7: 15-18, 1999

83. Hernández ER. Aplicación clínica de la FSH recombinante. En Avances en Menopausia y Reproducción. Vázquez (ed), Pag.136, 1999

84. Peramo B, Ricciarelli E, Hernández ER. Factores que influyen en los fallos de Fecundación In Vitro. Boletín de la SEF 8: 7-16, 1999

85. Peramo B, Ricciarelli E, Hernández ER. Mecanismo de Acción de las hormonas esteroides. En “Moduladores selectivos de los receptores de estrógenos (SERM): Aspectos básicos y clínicos”. A. Cano y J. Calaf (eds.), Doyma SA, Barcelona, pp 15-22, 1999

86. Cuadros J, Hernández ER. Transferencia citoplasmática. Boletín de ASEBIR 2:43-45, 1999

87. Hernandez ER. The clinical benefits of recombinant gonadotropins. Human Reproduction 15: 734-735, 2000

88. Hernandez ER. Embryo implantation: The rubicon for GnRH antagonist Human Reprod 15:1211-1216, 2000

89. Peñarrubia J, Balasch J, Garcia-Bermudez M, Casamitjana R, Vanrell JA, Hernández ER. Growth Hormone does not increase the expression of IGF-I and their receptor genes in the premenopausal human ovary. Human Reprod 15:1241-1246, 2000

90. Peramo B, Ricciareli E, Hernandez ER. Gestacion con agonistas de la GnRH. Progresos en Obstetricia y Ginecología. 43:521-526, 2000

91. Hernández ER. No room on the carrousel for meeting of like minds. Nature 407: 285, 2000

92. Hernández ER. Avoiding multiple pregnancies: sailing uncharted seas. Human Reproduction 16: 615-616, 2001

93. Hernández ER. El principio del fin de la donación de ovocitos. Rev Ibero Americana de Infert 18: 201-202, 2001

94. Hernández ER. La clonación. Progresos en Obstetricia y Ginecología. 44:281-282, 2001

95. Hernández ER. La clonación terapéutica. Rev IberoAmericana de Infert 18: 201-202, 2001

96. Roncero C, Hernandez ER. Introduccion a la biologia molecular. En: Biologia
Molecular en Medicina Reproductiva (Hernandez ER, Horcajadas JA, Simon C. Eds) Vol. 8 (2): 17-30, 2002. Panamericana, Madrid, España

97. Martinez M, Cuadros J, Andres L, Ricciarelli E, Hernandez ER. Técnicas en biologia molecular. En: Biologia Molecular en Medicina Reproductiva (Hernandez ER, Horcajadas JA, Simon C., Eds) Vol. 8 (2): 31-48, 2002.
Panamericana, Madrid, España

98. Cuadros J, Andres L, Martinez M, Ricciarelli E, Hernandez ER. Clonacion. En: Biologia Molecular en Medicina Reproductiva (Hernandez ER, Horcajadas JA, Simon C., Eds) Vol. 8 (2): 199-208, 2002. Panamericana, Madrid, España

99. Acevedo B, Gómez JL, Ricciarelli E, Hernández ER. Efectos secundarios de la punción transvaginal. Revista IberoAmericana de Infertilidad 20:31-34, 2003

100. Ricciarelli E, Sánchez-Burgos M, Sánchez M, Cuadros J, Hernández ER. Impact of the antagonist of GnRH in oocyte donation. Fertil Sterilility 79:1461-1463; 2003

101. Acevedo B, Gómez JL, Hernández ER Ricciarelli E. LH-supplementation increase pregnancy rates in GnRH antagonist donor cycles. Fertil Sterilility 82:343-347, 2004

102. Gómez JL Acevedo B, Ricciarelli E, Hernández ER. Timing ovulation for intrauterine insemination with a GnRH antagonist. Human Reproduction 20:368-372, 2005.

103. Gómez JL Acevedo B, Ricciarelli E, Hernández ER. LH improves early follicular recruitment in women over 38 years old. RBMOnline 11:409-414, 2005

104. Gómez JL Acevedo B, Ricciarelli E, Hernández ER. Requerimientos de la LH en estimulación ovárica: la ventana terapéutica. CMR 11:45-53, 2005

105. M Sánchez, J Cuadros, L Andrés, E Ricciarelli, ER Hernández. Diagnostico Genético Preimplantacional para enfermeras. Libro de “Reproducción Asistida para Enfermeras”. Publicado por la SEF.

106. Sanchez Aparicio P, Martinez M, Cuadros J, Ricciarelli E, Heranandez ER. Estudio de la expresion del gen de la insulina y su receptor en ovocitos y embriones humanos. Rev Iberoam Ferilidad 23: 387-394, 2006

107. Acebedo B, Gomez-Palomares JL, Ricciarelli E, Hernández, ER. Triggering ovulation with GnRH agonists does not compromise embryo implantability. Fertil Sterility 86:1682-87, 2006

108. Gomez-Palomares JL, Hernández, ER, Ricciarelli E. Multifollicular recruitment in combination with Gonadotropin-releasing hormone antagonist increased pregnancy rates in intrauterine insemination cycles. Fertil Steril. 2008, 89: 620-4.

109. Hernández, ER, Gomez-Palomares JL, Ricciarelli E. No room for cancellation, coasting, or ovarian hyperstimulation syndrome in oocyte donation cycles. Fertil Steril. 2009, 9: 1358-61.

110. Hernández ER. What next for preimplantation genetic screening (PGS)? Beyond Aneuploidy. Hum Reprod. 2009, 24:1538-41

111. Manzanares MA, Gómez-Palomares JL, Ricciarelli E, Hernández ER. Triggering ovulation with gonadotropin-releasing hormone agonist in vitro fertilization patients with polycystic ovaries does not cause ovarian hyperstimulation syndrome despite very high estradiol levels. Fertil Steril. 2010, 93:1215-9.

112. Hernandez ER, Nieto M, Gomez-Palomares JL. Fecundación e Implantación Embrionaria. En: Fundamentos de Reproducción (Arenas JM y Coroleu B, eds), SEGO y SEF, Madrid, 2010, pag. 36-40

113. Hernandez ER. Disfunción Reproductiva: una definición global de la infertilidad para el siglo 21. Rev Iberoam Fertilidad 28: 199-200, 2011

114. Manzanares MA, Ricciarelli E, Hernández ER. Ventajas de la maduración ovocitaria con análogos de la GnRH en TRA. Rev Iberoam Fertilidad 29: 129-135, 2012

115. Hernández ER. Desafíos médicos y legales en el futuro de la reproducción humana. En Reproducción Humana Asistida: Aspectos Jurídicos, Sociales y Psicológicos. 2013. Giuliana Baccino (ed.). Editorial Tirant Lo Blanch. Madrid

116. Baccino G, Salvadores P, Hernández ER. Disclosing their type of conception to offspring conceived by gamete or embryo donation in Spain. J Reproduction and Infant Psychol, 2013